Cardiovascular diseases are the leading cause of death worldwide and their incidence increases exponentially with age. In the lab of Dr. Korstanje, I am involved in stage 2 studies within the scope of the Interventions Testing Program, which is a long-standing NIA-funded program for pre-clinical compound screening in a mouse model. The goal is to use my experience in mouse genetics, cardiac pathology, and cardiac metabolomics to research anti-aging compounds that delay age-related decline of cardiac function and progression of cardiac pathology. I obtained my PhD from the University of Geneva, Switzerland (’19).
